The patient initiated with cisplatin, etoposide and sintilimab on November 5, 2024, but December 4, 2024, imaging revealed further progression of lung lesions ( Figures 1E, J , 2D )
The fact that people regained weight after stopping medication wasnt too surprising, but what was striking is just how fast it occurred. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing
Raftos JE, Whillier S, Kuchel PW
For bookings and enquiries: +32 (0) 2 669 29 70 | [email protected] | Organising Commitee Co-organised by the ILSI Europe Prebiotics Task Force and the Nutrition for the Ageing Brain Symposium Committee Georgia Chatonidi - rebro University Lars Christensen - Arla Louise Dye - University of Sheffield Robert Steinert - DSM Clmentine Thabuis - Roquette Sandrine Thuret - Kings College London Maria Tonti - ILSI Europe Wim Vandenberghe - University of Antwerp David Vauzour - University of East Anglia Jessica Van Harsselaar - Beneo Elaine Vaughan - Sensus
00:03:28 Vickie Danaher So how would you respond back to Jay
However, semaglutide use solely for weight loss has sparked debate within the medical community
